TOMI Environmental Solutions Disrupts the Dairy Industry with Major Mexican Dairy Brand
Rhea-AI Summary
TOMI Environmental Solutions (NASDAQ: TOMZ) announced a commercial deployment of SteraMist iHP at a major Mexican dairy facility on March 24, 2026. DisinfectCare conducted efficacy studies showing significant reductions in key pathogens and improved cheese preservation. An open purchase order covers seven pallets, about $128,000 USD of BIT Solution annually, with the first pallet shipping this month. DisinfectCare will use the SteraMist Environment System daily and the manufacturer may integrate SteraMist Hybrid Systems across additional sites to scale facility-wide disinfection.
The announcement cites projected growth in Mexico's food processing market and emphasizes expanded deployment and ongoing service adoption.
Positive
- Open purchase order for seven pallets (~$128,000 annually)
- Daily deployment of SteraMist Environment System at major dairy facility
- Efficacy studies showed significant reductions across tested pathogens
Negative
- Annual contract value (~$128,000) may be limited relative to large-scale revenue
- Expansion optionality depends on future site tests and deployments
Key Figures
Market Reality Check
Peers on Argus
Pre-news, TOMZ was up 3.41% while peers were mixed: LIQT +8.55%, CLIR -4.76%, CLWT +2.68%, DEVS -11.99%, ZONE +3.77%. Scanner momentum flagged only DEVS, reinforcing a stock-specific setup.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 18 | Food safety expansion | Positive | -2.7% | SteraMist iHP used to cut sanitation testing costs by up to 95%. |
| Mar 16 | Canadian expansion | Positive | +5.3% | Multiple SteraMist placements across Canadian hospitals and research institutions. |
| Mar 03 | EU partnership | Positive | -2.8% | Total Clean Air appointed preferred European partner for SteraMist iHP. |
| Feb 23 | Biocidal approvals | Positive | +12.7% | Biocidal product authorizations in Great Britain and Northern Ireland for SteraMist. |
| Jan 20 | Custom system sale | Positive | +0.6% | Sale of custom engineered SteraMist system into UK pharmaceutical cleanroom platform. |
Recent positive partnership and expansion headlines have produced mixed price reactions, with both strong gains and notable divergences.
Over recent months, TOMI has reported multiple SteraMist iHP expansion wins across geographies. Highlights include Canadian hospital deployments on Mar 16, 2026, European partnership designations on Mar 3, 2026, and biocidal approvals in Great Britain and Northern Ireland on Feb 23, 2026. A custom engineered system sale was disclosed on Jan 20, 2026. Today’s Mexican dairy agreement extends this pattern of applying SteraMist into new verticals and regions.
Regulatory & Risk Context
An effective S-3 shelf filed on Nov 14, 2025 allows TOMI to offer up to $50,000,000 of various securities in one or more future offerings for general corporate purposes.
Market Pulse Summary
This announcement details a Mexican dairy manufacturer’s adoption of SteraMist iHP, including an open order covering seven pallets of BIT Solution, or about $128,000 annually, within a Mexican food processing market projected to reach $5.75 billion by 2033. In context with prior hospital, pharmaceutical, and international wins, investors may track how recurring consumable sales scale across sites, while also monitoring the $50,000,000 S-3 shelf and Nasdaq compliance milestones disclosed in recent filings.
Key Terms
pathogen medical
cagr financial
AI-generated analysis. Not financial advice.
Rigorous Pathogen Testing and Proven Preservation Results Drive SteraMist Adoption at Major Mexican Dairy Facility
FREDERICK, Md., March 24, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today revealed that a leading Mexican dairy manufacturer has secured ongoing SteraMist iHP services to maintain its high-standard facility sanitation.
TOMI’s long-standing relationship with DisinfectCare has facilitated the implementation of SteraMist service at a major dairy facility in Mexico. Prior to purchase, DisinfectCare conducted multiple efficacy studies at the manufacturer’s site by evaluating SteraMist iHP by applying directly on cheese and assessing the efficacy against key industry pathogens, including Staphylococcus aureus, Total coliforms, Escherichia coli, Aerobic mesophilic bacteria, Fungi, and Yeast. Results demonstrated significant reductions across all tested organisms, most notably among mesophilic bacteria, a category that can include dangerous pathogens such as Listeria monocytogenes. Testing has also demonstrated meaningful improvement in cheese preservation. Following these successful tests, the service provider and manufacturer selected SteraMist iHP as its preferred disinfection solution.
DisinfectCare will deploy the SteraMist Environment System daily. Utilizing gallons of BIT Solution per day, the solution purchase is structured under an open purchase order for seven (7) pallets, approximately
"This partnership represents exactly the kind of strategic collaboration the food and beverage industry needs more of, bringing together established brand power with genuine, technological innovation to solve real consumer problems,” said Elissa J. (E.J.) Shane, Chief Operating Officer of TOMI Environmental Solutions. “The rigorous pathogen reduction data this service provider achieved at this dairy manufacturer speaks for itself. SteraMist is proving that it does not just meet the demanding safety and preservation standards of large-scale food manufacturing, it raises them. We look forward to growing alongside this manufacturer as they expand their facilities and operations."
The Food Processing Market in Mexico is projected to surge from US
About TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.
TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.
For additional information, please visit https://www.steramist.com or contact us at info@tomimist.com.
Forward-Looking Statements
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products and services serving the food safety sector. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to acquire new customers and expands sales; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Zach Nevas
IMS Investor Relations
FAQ
What did TOMZ announce on March 24, 2026 about SteraMist at a Mexican dairy?
How much is the open purchase order for TOMZ's BIT Solution with the Mexican dairy?
What pathogen reductions did TOMZ report from SteraMist testing at the dairy facility?
Will TOMZ's SteraMist be deployed across additional sites for the dairy manufacturer?
What SteraMist systems will DisinfectCare use at the Mexican dairy facility (TOMZ)?
